Hydromorphone Hydrochloride marketed by Ascent Pharmaceuticals, Inc. under NDC Code 43602-268-30
NDC Code(s) : 43602-266-30, 43602-266-05, 43602-267-30, 43602-267-05, 43602-268-30, 43602-268-05, 43602-269-30, 43602-269-05
Packager : Ascent Pharmaceuticals, Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : CII
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
hydromorphone hydrochloridehydromorphone hydrochloride TABLET, EXTENDED RELEASE |
|
|
|
|
|
|
hydromorphone hydrochloridehydromorphone hydrochloride TABLET, EXTENDED RELEASE |
|
|
|
|
|
|
hydromorphone hydrochloridehydromorphone hydrochloride TABLET, EXTENDED RELEASE |
|
|
|
|
|
|
hydromorphone hydrochloridehydromorphone hydrochloride TABLET, EXTENDED RELEASE |
|
|
|
|
|
|
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.